The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
RE: Pancreatic cancer needs breakthrough therapy12 Mar 2024 10:43
Me too CTSFO, trouble is Avacta are not in the position to deliver AVA6000 to the masses and I don't think they ever will be. I'm hoping for the sake of cancer patients we get bought out by BP and pdq. To be honest I've lost all faith in Avacta delivering anything.